| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), TPST's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 231.5K | $500.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 10, 2016 | Dipp Michelle | Chief Executive Officer | Buy | 19,900 | $7.72 | $153,628.00 | +5.0% | |
| May 10, 2016 | Aldrich Richard | Director | Buy | 19,900 | $7.72 | $153,628.00 | +5.0% | |
| Mar 24, 2016 | Aldrich Richard | Director | Buy | 59,800 | $9.49 | $567,240.39 | +17.5% | |
| Mar 24, 2016 | Dipp Michelle | Chief Executive Officer | Buy | 59,800 | $9.49 | $567,240.39 | +17.5% | |
| Mar 22, 2016 | Aldrich Richard | Director | Buy | 59,800 | $10.44 | $624,513.61 | +21.2% | |
| Mar 22, 2016 | Dipp Michelle | Chief Executive Officer | Buy | 59,800 | $10.44 | $624,513.61 | +21.2% | |
| Mar 18, 2016 | Aldrich Richard | Director | Buy | 59,700 | $8.26 | $492,962.43 | +26.9% | |
| Mar 18, 2016 | Dipp Michelle | Chief Executive Officer | Buy | 59,700 | $8.26 | $492,962.43 | +26.9% | |
| Mar 16, 2016 | Aldrich Richard | Director | Buy | 59,029 | $7.90 | $466,104.20 | +36.3% | |
| Mar 16, 2016 | Dipp Michelle | Chief Executive Officer | Buy | 59,029 | $7.90 | $466,104.20 | +36.3% |